| Product NDC: | 21695-633 |
| Proprietary Name: | Chantix |
| Non Proprietary Name: | varenicline tartrate |
| Active Ingredient(s): | .5 mg/1 & nbsp; varenicline tartrate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 21695-633 |
| Labeler Name: | Rebel Distributors Corp |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021928 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20060510 |
| Package NDC: | 21695-633-56 |
| Package Description: | 56 TABLET, FILM COATED in 1 BOTTLE (21695-633-56) |
| NDC Code | 21695-633-56 |
| Proprietary Name | Chantix |
| Package Description | 56 TABLET, FILM COATED in 1 BOTTLE (21695-633-56) |
| Product NDC | 21695-633 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | varenicline tartrate |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20060510 |
| Marketing Category Name | NDA |
| Labeler Name | Rebel Distributors Corp |
| Substance Name | VARENICLINE TARTRATE |
| Strength Number | .5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Partial Cholinergic Nicotinic Agonist [EPC],Partial Cholinergic Nicotinic Agonists [MoA] |